Remdesivir manufacturers to cut price, ramp up production amid Covid-19 spike
Manufacturers of Remdesivir have volunteered to reduce the price to less than ₹3,500 by end of this week
Seven Indian companies are producing Injection Remdesivir under voluntary licensing agreement with M/s. Gilead Sciences, USA
Amid the shortage of the anti-viral drug Remdesivir in the wake of surge in novel coronavirus cases in the country, the Indian government on Wednesday said that after a recent meeting with all-existing manufacturers of the drug and other stakeholders, decisions have been taken to increase production and supply and reduce prices of Remdesivir.